Liver biopsy samples from patients during bariatric surgery revealed that, compared to non-NASH patients, patients with NASH exhibit significantly higher expression of NLRP3 inflammasome-related proteins, including NLRP3, pre-IL-1β, and pre-IL-18 (66). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.